CA19-9 (19C7HC)
| $326.00 | |
| V08401-1 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $326.00 | |
| V08401-1 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Specificity | Human CA19-9 |
| Clone ID | 19C7HC |
| Isotype | Recombinant human IgG1 for Mab 19C7HC |
| Production | Cultured in vitro under conditions free from animal-derived components |
| Purification | Protein A/G affinity column |
| Formulation | 50 mM Na-citrate, 150 mM NaCl, pH 7.0, containing 0.03% ProClin 300. |
| Storage | For long term storage, aliquot and store at -25°C~-15°C or below. Avoid repeated freezing and thawing cycles. |
| Note | GenScript can customize this product per customer's request including product size, buffer components, etc. |
|
|||||||||
| Target Background | Carbohydrate antigen 19-9 (CA19-9) is the sialylated form of Lewis Antigen. It may be elevated in many types of gastrointestinal cancer, such as colorectal cancer, esophageal cancer and hepatocellular carcinoma. It is useful for diagnosis and monitoring of pancreatic cancer |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.